Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Business

Lancaster University spinout wins major backing to revolutionise healthcare diagnostics

by February 6, 2025
February 6, 2025
Lancaster University spinout wins major backing to revolutionise healthcare diagnostics

Lancaster-based startup CCI Photonics has secured significant new funding to develop its groundbreaking technology for rapid infection detection and antibiotic screening.

Launched by Lancaster University researchers, the spinout aims to deliver test results in as little as 15 minutes—dramatically faster than traditional methods, which can take up to 72 hours.

The investment pot includes £200,000 from the Northern Powerhouse Investment Fund II (NPIF II) PraeSeed programme, £150,000 from the Infection Innovation Consortium (iiCON), and £100,000 from Lyva Labs via Liverpool City Region Combined Authority. CCI Photonics has also received backing from ICURe Innovate UK and holds additional support through a UKRI Novel Technologies Grant.

At the heart of this innovation is InfectiScan, a powerful in vitro diagnostic device that uses infrared spectrometry and advanced AI models to pinpoint bacterial infections in bodily fluids—and determine the most effective antibiotics to prescribe. Founded on research undertaken in partnership with the University Hospitals of Morecambe Bay NHS Foundation Trust (UHMBT), the technology is designed to tackle antibiotic resistance by reducing the guesswork in prescribing antibiotics.

Current diagnostic tools often leave clinicians prescribing treatments on a “best guess” basis, contributing to the rise of antibiotic resistance and increasing the likelihood of ineffective care or infection recurrence. With CCI Photonics’ InfectiScan device, healthcare professionals will be able to rapidly identify pathogens and confirm antibiotic suitability, significantly improving patient outcomes.

Dr Meza Ramirez, Chief Executive of CCI Photonics, emphasised: “This funding allows us to take critical steps in validating and refining our technology. With the support of our partners, we are working to bring a practical solution to healthcare challenges.”

Professor Craig Williams, Consultant Microbiologist at UHMBT, echoed this sentiment: “I hope this ongoing research will provide much more rapid diagnosis, leading to better infection treatment outcomes at a time when bacteria are becoming more resistant to commonly used antibiotics.”

Professor Janet Hemingway, founding director of iiCON, also underlined the importance of disruptive technologies in the fight against infectious diseases, noting the urgent global health challenge and the need for swift innovation.

By combining world-class research, strong funding, and practical clinical collaboration, CCI Photonics is poised to transform infectious disease diagnostics—potentially slashing test turnaround times from days to minutes and helping to stave off the looming threat of antibiotic resistance.

Read more:
Lancaster University spinout wins major backing to revolutionise healthcare diagnostics

0
FacebookTwitterGoogle +Pinterest
previous post
BT scraps diversity targets from managers’ bonuses
next post
Re N Tox: Medical Spa RX Delivers a Breakthrough in Wrinkle Treatment

You may also like

Business leaders want regulatory stability rather than a...

May 3, 2023

Labelling Machines in Modern Era of On-Demand Operations

September 11, 2023

UK workforce set to hit record low as...

December 13, 2024

The Restaurant Group sees first sign of customers...

September 9, 2022

Pay inflation peaks as labour market cools, but...

December 4, 2023

Spotify cuts almost 1,600 jobs amid rising costs

December 4, 2023

TikTok reports five-fold surge in turnover to hit...

October 5, 2022

Energy subsidies lift UK borrowing to February high

March 21, 2023

Tata confirm decision to build £4bn gigafactory in...

July 19, 2023

Housebuilders ‘lobbied against plan for electric car chargers...

September 12, 2022

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Brazil’s Supreme Court Rewrites the Rules to Censor Online Speech

      June 27, 2025
    • Trump secures record-shattering $1.4B for political war chest; will be ‘dominant force’ for GOP in midterms

      June 27, 2025
    • Trump says ‘big, beautiful’ bill ‘must’ meet deadline as some Republicans waver

      June 27, 2025
    • Friday Feature: Savannah Legacy Academy

      June 27, 2025
    • The Supreme Court Is Right on Reading Opt-Outs, But That’s Not Enough

      June 27, 2025
    • Barrett eviscerates Jackson, Sotomayor takes on a ‘complicit’ court in contentious final opinions

      June 27, 2025

    Categories

    • Business (8,329)
    • Investing (2,080)
    • Politics (15,837)
    • Stocks (3,174)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved